(Q43754734)

26 November 2017

title

Renal sympathetic denervation therapy in the real world: results from the Heidelberg registry (English)

1 reference

26 November 2017

12

Hugo A Katus

1 reference

26 November 2017

5

Benjamin Meder

1 reference

26 November 2017

Britta Vogel

1

1 reference

26 November 2017

Michael Kirchberger

2

1 reference

26 November 2017

Martin Zeier

3

1 reference

26 November 2017

Felicitas Stoll

4

1 reference

26 November 2017

Daniel Saure

6

1 reference

26 November 2017

Martin Andrassy

7

1 reference

26 November 2017

Oliver J Mueller

8

1 reference

26 November 2017

Stefan Hardt

9

1 reference

26 November 2017

Vedat Schwenger

10

1 reference

26 November 2017

Anna Strothmeyer

11

1 reference

26 November 2017

Erwin Blessing

13

1 reference

26 November 2017

publication date

15 October 2013

1 reference

Clinical Research in Cardiology

26 November 2017

published in

1 reference

26 November 2017

volume

103

1 reference

26 November 2017

issue

2

1 reference

26 November 2017

page(s)

117-124

1 reference

https://scigraph.springernature.com/pub.10.1007/s00392-013-0627-5

26 November 2017

exact match

0 references

cites work

Hypertension treatment and control in five European countries, Canada, and the United States

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0627-5

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0627-5

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0627-5

Executive Summary: Heart Disease and Stroke Statistics—2010 Update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0627-5

Resistant hypertension: an overview of evaluation and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0627-5

Sympatho-renal axis in chronic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0627-5

Renal sympathetic-nerve ablation for uncontrolled hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0627-5

Catheter-based renal sympathetic denervation: chronic preclinical evidence for renal artery safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0627-5

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0627-5

Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0627-5

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0627-5

Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0627-5

Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0627-5

Renal sympathetic denervation for treatment of electrical storm: first-in-man experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0627-5

Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0627-5

Renal sympathetic denervation provides ventricular rate control but does not prevent atrial electrical remodeling during atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0627-5

Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0627-5

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0627-5

Expert consensus document from the European Society of Cardiology on catheter-based renal denervation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0627-5

Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0627-5

Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study

21 January 2018

1 reference

12 December 2020

Effect of renal sympathetic denervation on the inducibility of atrial fibrillation during rapid atrial pacing

1 reference

12 December 2020

Global burden of hypertension: analysis of worldwide data

1 reference

12 December 2020

Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension

1 reference

12 December 2020

Renal denervation: a potential new treatment modality for polycystic ovary syndrome?

1 reference

12 December 2020

Updated ESH position paper on interventional therapy of resistant hypertension

1 reference

12 December 2020

Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial

1 reference

12 December 2020

10.1007/S00392-013-0627-5

Identifiers

DOI

1 reference

26 November 2017

1 reference